Seaport Therapeutics, Inc.
SPTX
$24.22
$0.512.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 41.19M | 6.11M | 5.06M | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 65.57M | 26.98M | 17.86M | ||
| Operating Income | -65.57M | -26.98M | -17.86M | ||
| Income Before Tax | -62.35M | -24.89M | -14.94M | ||
| Income Tax Expenses | 251.00K | 519.00K | 134.00K | ||
| Earnings from Continuing Operations | -62.60M | -25.41M | -15.08M | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -62.60M | -25.41M | -15.08M | ||
| EBIT | -65.57M | -26.98M | -17.86M | ||
| EBITDA | -65.55M | -26.95M | -17.82M | ||
| EPS Basic | -1.78 | -10.34 | -6.40 | ||
| Normalized Basic EPS | -1.11 | -6.33 | -3.96 | ||
| EPS Diluted | -1.78 | -10.34 | -6.40 | ||
| Normalized Diluted EPS | -1.11 | -6.33 | -3.96 | ||
| Average Basic Shares Outstanding | 35.24M | 2.46M | 2.36M | ||
| Average Diluted Shares Outstanding | 35.24M | 2.46M | 2.36M | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||